Deep Brain Stimulation for Bipolar Depression
(PReSiDio-BP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new treatment for bipolar depression using a device that sends small electrical signals to the brain. The goal is to determine if this personalized brain stimulation, known as Closed-Loop Deep Brain Stimulation, can reduce symptoms in individuals whose depression hasn't improved with other treatments. Participants will have the device implanted to monitor and adjust their brain activity. The trial seeks individuals with bipolar depression who have struggled with symptoms for at least a year despite trying other therapies.
As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could lead to new treatment options for bipolar depression.
Will I have to stop taking my current medications?
You will need to continue taking your current mood stabilizer or antipsychotic medication throughout the study unless it's necessary to stop for safety reasons. If you're on a stable regimen of psychotropic medication, no changes should be expected during the 4 weeks before and throughout the study.
What prior data suggests that the NeuroPace Responsive Neurostimulation (RNS) System is safe for treating bipolar depression?
Studies have shown that deep brain stimulation (DBS) can safely treat various conditions. For example, DBS has helped people with obsessive-compulsive disorder (OCD) when other treatments failed. In another study, researchers tested DBS on patients with difficult-to-treat depression, and about 66% showed improvement after six months.
The device used in the current trial, the NeuroPace Responsive Neurostimulation (RNS) System, has already received FDA approval for treating epilepsy, indicating it has been tested for safety in people with that condition. While researchers continue to study DBS for bipolar depression, earlier findings suggest it might be well-tolerated. Each person's experience can differ, so discussing any concerns with a healthcare provider is important.12345Why are researchers excited about this trial?
Researchers are excited about closed-loop deep brain stimulation for bipolar depression because it offers a unique approach compared to current treatments like mood stabilizers and antidepressants. Unlike these medications, which often take weeks to show effects and can have significant side effects, closed-loop deep brain stimulation uses targeted electrical impulses to regulate brain activity in real-time. This method has the potential to provide more immediate relief from symptoms and can be adjusted to the patient's needs, offering a personalized treatment experience. By directly modulating brain circuits involved in mood regulation, this technique could revolutionize how we manage bipolar depression.
What evidence suggests that the NeuroPace RNS System could be effective for treating bipolar depression?
Research shows that deep brain stimulation (DBS) could help treat severe depression cases. Studies have found that DBS benefits 60% of people who haven't improved with other treatments. In some studies, patients experienced a 43% decrease in depression symptoms 12 months after the device activation. By 24 months, this decrease improved to 53%. This trial will evaluate different stimulation settings, including continuous stimulation, sham control, and fixed intermittent stimulation, to determine the most effective approach. The study's personalized approach aims to adjust the treatment to fit each person's unique brain activity.25678
Who Is on the Research Team?
Andrew Krystal, MD, MS
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for individuals with treatment-resistant bipolar depression. Participants must have a history of inadequate response to standard therapies. The study involves those who are eligible for brain surgery to implant a device that will deliver electrical impulses.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Stage 1: Electrode Implantation and Testing
Surgical implantation of electrodes to identify personalized treatment sites and test stimulation effects on bipolar depression symptoms. Electrodes are removed at the end of this stage.
Stage 2: NeuroPace RNS System Implantation
Second brain surgery to implant the NeuroPace RNS System. Regular clinic visits to determine personalized brain activity patterns for stimulation.
Stage 3: Crossover Trial
36-40 weeks of testing the effectiveness of closed-loop stimulation with variable start times and three 12-week periods: closed-loop stimulation, open-loop/fixed intermittent stimulation, and sham.
Follow-up
Participants are monitored for safety and effectiveness after treatment. Option to continue with long-term follow-up or have the RNS System removed.
What Are the Treatments Tested in This Trial?
Interventions
- Closed-Loop Deep Brain Stimulation
Trial Overview
The trial tests the NeuroPace Responsive Neurostimulation (RNS) System, which is FDA approved for epilepsy but now being studied for bipolar depression. It measures and alters brain activity via electrical stimulation to see if it can reduce depressive symptoms.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
Placebo Group
This is a crossover trial. Each patient will receive 12 wks of stimulation ON (arm 1), stimulation OFF (arm 2), and Stimulation ON Active Control (fixed intermittent) (arm 3) in random order.
This is a crossover trial. Each patient will receive 12 wks of stimulation ON (arm 1), stimulation OFF (arm 2), and Stimulation ON Active Control (fixed intermittent) (arm 3) in random order.
This is a crossover trial. Each patient will receive 12 wks of stimulation ON (arm 1), stimulation OFF (arm 2), and Stimulation ON Active Control (fixed intermittent) (arm 3) in random order.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Andrew Krystal
Lead Sponsor
Citations
Study Details | NCT06599099 | Deep Brain Stimulation of ...
This research study is to investigate the use of technology called Deep Brain Stimulation (DBS) to potentially improve Treatment-Resistant Bipolar Depression ( ...
Deep Brain Stimulation for Depression - PMC - PubMed Central
DBS across different targets is associated with on average 60% response rates in previously refractory chronically depressed patients. However, ...
Revisiting subcallosal cingulate deep brain stimulation for ...
Average MADRS reduction was 43 % at 12 months and 53 % at 24 months post-device activation, with response rates of 46 % and 55 %, and partial response rates of ...
Closed-loop neuromodulation in an individual with ...
Deep brain stimulation is a promising treatment for neuropsychiatric conditions such as major depression.
Closed-Loop Deep Brain Stimulation for Treatment ...
The purpose of this study is to test a personalized approach to brain stimulation as an intervention for bipolar depression The study researchers will use a ...
Closed Loop Deep Brain Stimulation for Psychiatric Disorders
DBS has strong open-label evidence in OCD, with multiple groups reporting 60-70% response rates in otherwise treatment-refractory cases, across a variety of ...
Deep Brain Stimulation for Depression
The first open-label trial of DBS for TRD conducted by Mayberg et al. demonstrated its safety and efficacy, with a response rate (RS) at 6 months of 66% and ...
How impactful is deep brain stimulation for depression?
The robust and sustained clinical effects of DBS in multiple open-label trials highlight the potential impact of DBS for long-term depression treatment. The ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.